文献速递食管与纵隔外科

食管癌术后孤立性脑转移的发生率与危险因素

Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain.
PubMed 文献 · Ann Thorac Surg · 2019-10-12

研究基于1760例食管癌切除术患者的前瞻性数据库,发现38例孤立性脑转移(iBMEC),占2%。iBMEC患者中位总生存0.95年,超过半数在术后1年内诊断,且所有患者均接受过新辅助治疗;新辅助治疗后病理完全缓解(PCR)与脑转移后生存改善相关。

要点

  • 食管癌术后iBMEC发生率约2%,多数在术后1年内诊断。
  • 所有iBMEC患者均接受过新辅助治疗,PCR者脑转移后生存更优。
  • 接受新辅助治疗者或可从术前及常规随访脑成像中获益。

核心结论

  • 食管癌术后孤立性脑转移虽罕见但预后差,新辅助治疗尤其PCR患者可能从脑成像监测中获益。

研究设计与样本

  • 基于前瞻性食管癌切除术患者数据库的回顾性分析,共纳入1760例患者,其中38例发生iBMEC,采用竞争风险回归分析危险因素。

主要发现

  • 全队列中39%患者复发,iBMEC发生率为2%。
  • iBMEC患者中位总生存为0.95年(95%CI 0.6-1.5年),与远处复发患者相似。
  • 超过半数iBMEC在术后1年内诊断,所有38例均接受过新辅助治疗。

关键数值与推荐

  • iBMEC定义:食管癌术后孤立性脑转移。

临床怎么用

  • 对接受新辅助治疗的食管癌术后患者,尤其PCR者,可考虑术前及常规随访中增加脑成像检查。

局限性

  • iBMEC病例数较少(n=38),可能限制统计效能。
  • 原文未报告竞争风险回归的具体危险因素及效应值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recurrence of esophageal cancer in the brain is rare but associated with a poor prognosis. Identification of risk factors for isolated brain metastasis of esophageal cancer (iBMEC) after surgical treatment may guide surveillance recommendations to enable early identification and intervention before widespread metastasis. METHODS: Patients with iBMEC (n = 38) were identified from a prospective database of patients with esophageal cancer who underwent esophagectomy. Risk factors for iBMEC were identified using competing risk regression analysis. RESULTS: In a cohort of 1760 patients, 39% recurred and iBMEC developed in 2% by the end of the study. Survival in patients with iBMEC was similar to survival in patients with distant recurrence (median overall survival, 0.95 years; 95% confidence interval, 0.6-1.5 years). More than half of patients with iBMEC were diagnosed within 1 year postoperatively. All 38 patients with iBMEC had received neoadjuvant therapy before surgery. Pathologic complete response (PCR) to neoadjuvant therapy was associated with improved survival after brain recurrence (median overall survival, 1.56 vs 0.66 years; P = .019). CONCLUSIONS: In patients with PCR, iBMEC may represent true isolated recurrence, whereas in those with residual nodal disease, iBMEC may actually be the first observed site of widespread metastasis. Patients who receive neoadjuvant therapy, especially with PCR, may benefit from brain imaging, both preoperatively and with routine surveillance.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Nobel TB, Dave N, Eljalby M, et al. Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain. Ann Thorac Surg. 2019. PMID: 31614136. doi:10.1016/j.athoracsur.2019.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。